IndraLab

Statements


USP39 decreases the amount of CDKN1A. 1 / 1
| 1

reach
"Furthermore, silencing of USP39, a target of miR-1281 in human osteosarcoma cells, inhibits survival under endoplasmic reticulum stress and slows the metastasis of malignant bone tumors to other tissues and organs by increasing the expression of Cyclin A2 and p21, leading to cell cycle arrest in the G2/M phase and promoting apoptosis [43, 92, 93]."